Category Archives: 2018

PeproMene Bio Appoints Steven T. Rosen, MD, to the Scientific Advisory Board

Posted on June 22, 2018 by lhg-dev

Irvine, CA, June 22, 2018 – PeproMene Bio, Inc., a development stage biotechnology company focused on BAFF-R target CAR-T cell to develop novel cancer and immuno-oncology therapies, today announced the appointment of Steven T. Rosen as its Scientific Advisor. Bryan … Continue reading →

Posted in 2018 | Leave a comment